Pfizer PFE Ratios (2009-2026)

NYSE PFE
$29.24 -0.15 (-0.51%)
At close: Nov 9, 2026 · 4:00 PM EST
Reported Financials

Pfizer Quarterly Ratios

Periods 71 quarters
Latest Sep 2026

Pfizer reported a gross margin of 75.71% and a net margin of 19.55% for the quarter ended Sep 2026. These financial ratios cover 71 quarters of results from Mar 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Mar2009 Jun2009 Sep2009 Dec2009 Apr2010 Jul2010 Oct2010 Dec2010 Apr2011 Jul2011 Oct2011 Dec2011 Apr2012 Jul2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Apr2016 Jul2016 Oct2016 Dec2016 Apr2017 Jul2017 Oct2017 Dec2017 Apr2018 Jul2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Apr2021 Jul2021 Oct2021 Dec2021 Apr2022 Jul2022 Oct2022 Dec2022 Apr2023 Jul2023 Oct2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Profitability
Gross Margin
59.16%61.09%68.83%73.22%61.62%73.57%75.11%31.29%48.09%77.29%75.16%70.27%66.73%79.26%74.22%74.95%69.97%75.45%72.78%75.71%
EBT Margin
16.05%35.27%41.26%39.76%20.81%33.92%17.44%-24.85%-28.34%22.99%-0.78%26.64%-0.06%20.31%20.77%20.02%-9.35%21.94%-4.34%20.41%
EBIT Margin
26.92%41.27%47.01%45.45%25.59%41.77%26.22%-14.27%-20.25%36.36%17.44%35.50%21.36%36.15%34.48%38.81%24.56%37.04%28.37%32.98%
EBITDA Margin
32.52%45.90%51.25%50.68%31.63%49.81%38.32%-2.71%-8.79%48.03%30.46%45.41%31.45%47.95%45.57%48.79%34.17%48.20%39.16%42.49%
Operating Margin
26.92%41.27%47.01%45.45%25.59%41.77%26.22%-14.27%-20.25%36.36%17.44%35.50%21.36%36.15%34.48%38.81%24.56%37.04%28.37%32.98%
Net Margin
14.23%30.65%35.71%38.02%19.87%29.98%17.89%-17.66%-23.12%20.94%0.31%25.22%2.31%21.63%19.86%21.26%-9.39%18.59%-1.65%19.55%
FCF Margin
20.67%22.98%26.76%22.65%30.16%0.39%-16.31%19.61%28.80%2.59%-18.20%34.25%32.67%12.91%-8.19%24.02%25.65%15.08%2.01%28.96%
Efficiency
Inventory AverageInventory Avg.
8,849.50M9,519.00M10,216.50M9,983.50M9,247.00M9,261.00M9,925.50M10,257.00M10,196.50M10,540.50M11,169.50M11,584.00M11,286.00M10,851.50M11,260.50M11,568.50M11,061.00M10,660.50M10,306.00M9,983.50M
Assets AverageAssets Avg.
180,332.00M182,738.00M189,645.00M195,320.00M196,277.50M196,602.50M208,084.00M217,594.50M221,010.50M224,047.50M218,644.00M217,834.50M216,436.00M210,712.00M207,061.50M207,547.50M208,580.00M208,080.00M204,565.50M203,065.50M
Equity AverageEquity Avg.
76,714.50M80,073.50M85,077.00M90,180.00M94,403.50M98,576.00M100,264.50M98,248.50M93,246.00M90,923.00M90,266.50M90,266.50M90,527.50M89,567.00M89,824.50M91,054.00M89,935.50M88,589.50M87,948.00M87,396.50M
Invested CapitalInvested Cap.
115,898.00M118,986.00M127,753.00M129,560.00M131,861.00M137,128.00M164,634.00M160,800.00M161,638.00M162,097.00M157,425.00M160,259.00M152,848.00M152,746.00M150,809.00M154,808.00M151,570.00M154,859.00M148,686.00M151,972.00M
Asset Utilization RatioAsset Util.
0.450.510.530.510.520.480.380.320.270.250.260.280.290.300.310.300.300.300.310.31
Leverage & Solvency
Debt Ratio
0.210.200.210.190.180.180.300.300.320.310.320.310.300.300.300.300.310.310.310.31
Dividends & Payouts
Dividend Coverage RatioDiv. Cover
1.553.504.413.832.222.411.01-1.03-1.461.310.021.880.171.221.191.45-0.671.10-0.101.32
FCF Payout RatioFCF Cover
0.440.380.300.440.3031.550.870.556.150.390.411.380.610.541.128.120.51
Dividend YieldDiv. Yield
2.63%3.04%3.02%3.63%3.12%3.92%4.40%4.90%5.69%5.92%5.92%5.73%6.33%6.68%7.01%7.18%6.90%6.35%7.07%5.99%
Payout Ratio
0.400.350.300.300.290.310.420.884.362.221.181.210.900.991.261.312.262.43
Valuation
Price to EarningsP/E
15.1111.5910.028.259.187.939.6417.8776.7238.7718.7218.1812.7913.7518.2220.5831.9640.53
Price to SalesP/S
4.083.132.902.462.852.452.612.672.732.812.822.732.362.292.152.152.262.432.172.57
Price to BookP/B
4.293.503.362.643.002.282.091.931.821.701.801.781.701.581.551.451.631.701.621.83
Enterprise Value
301,251.60M265,717.89M260,539.13M209,774.63M265,445.39M210,622.52M162,582.80M143,380.52M150,154.76M145,595.95M151,729.13M155,172.74M130,171.55M126,310.06M124,601.47M120,403.41M128,291.06M141,340.98M127,048.08M149,498.81M
EV to EBIT
11.328.406.875.206.585.625.849.1724.0036.9053.2214.037.317.286.205.946.176.676.237.71
EV to EBITDA
9.477.226.064.645.844.924.846.5811.9713.8915.898.645.255.214.644.474.695.094.715.77
Market Capitalization
332,058.60M289,353.89M293,582.13M245,638.63M287,921.39M230,328.52M207,093.80M187,291.52M162,570.76M157,247.95M158,554.13M164,852.74M150,354.55M143,328.06M137,533.47M135,092.41M141,588.06M154,112.98M138,445.08M163,471.81M
Price to FCFP/FCF
10.999.0110.2010.5111.0611.4019.4322.9033.9230.8032.9620.0415.2912.7711.0613.0215.6016.2512.6013.87
EV to FCF
9.978.279.058.9710.2010.4215.2517.5331.3328.5131.5418.8613.2411.2610.0211.6014.1414.9011.5712.68
EV to CFO
9.157.618.197.889.078.8011.1711.9117.2616.9718.9513.7810.219.038.209.2110.9611.799.4810.55
Return Ratios
Return on Sales [ROS]ROS
26.92%41.27%47.01%45.45%25.59%41.77%26.22%-14.27%-20.25%36.36%17.44%35.50%21.36%36.15%34.48%38.81%24.56%37.04%28.37%32.98%
Return on Capital Employed [ROCE]ROCE
19.33%22.05%26.67%26.71%26.18%23.42%16.06%8.39%3.61%2.15%1.63%6.33%10.27%9.96%11.86%11.86%12.11%12.19%11.86%11.32%
Return on Invested Capital [ROIC]ROIC
21.21%24.78%28.20%28.20%27.91%25.37%17.46%9.61%3.88%0.35%1.10%6.96%11.37%11.36%13.24%13.26%13.57%13.15%13.44%12.34%
Return on Assets [ROA]ROA
12.21%13.69%15.47%15.25%16.00%14.80%10.34%4.84%0.98%-0.12%-1.17%1.97%3.72%3.75%5.21%4.76%3.74%3.62%2.14%2.00%
Return on Equity [ROE]ROE
28.71%31.23%34.48%33.04%33.27%29.51%21.46%10.71%2.31%-0.30%-2.84%4.75%8.91%8.83%12.01%10.84%8.69%8.50%4.97%4.66%

Pfizer Ratios API

Pull Pfizer's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PFE&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY